291 related articles for article (PubMed ID: 28855387)
1. A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.
Alves AC; Ribeiro D; Horta M; Lima JLFC; Nunes C; Reis S
J R Soc Interface; 2017 Aug; 14(133):. PubMed ID: 28855387
[TBL] [Abstract][Full Text] [Related]
2. The daunorubicin interplay with mimetic model membranes of cancer cells: A biophysical interpretation.
Alves AC; Ribeiro D; Horta M; Lima JL; Nunes C; Reis S
Biochim Biophys Acta Biomembr; 2017 May; 1859(5):941-948. PubMed ID: 28153496
[TBL] [Abstract][Full Text] [Related]
3. Daunorubicin and doxorubicin molecular interplay with 2D membrane models.
Alves AC; Nunes C; Lima J; Reis S
Colloids Surf B Biointerfaces; 2017 Dec; 160():610-618. PubMed ID: 29028609
[TBL] [Abstract][Full Text] [Related]
4. pH dependence of daunorubicin interactions with model DMPC:Cholesterol membranes.
Matyszewska D; Brzezińska K; Juhaniewicz J; Bilewicz R
Colloids Surf B Biointerfaces; 2015 Oct; 134():295-303. PubMed ID: 26209780
[TBL] [Abstract][Full Text] [Related]
5. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale dynamics of phospholipids reveals an optimal assembly mechanism of pore-forming proteins in bilayer membranes.
Sarangi NK; Ayappa KG; Visweswariah SS; Basu JK
Phys Chem Chem Phys; 2016 Nov; 18(43):29935-29945. PubMed ID: 27762416
[TBL] [Abstract][Full Text] [Related]
7. Drug-membrane interaction studies applied to N'-acetyl-rifabutin.
Pinheiro M; Arêde M; Caio JM; Moiteiro C; Lúcio M; Reis S
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):597-603. PubMed ID: 23523541
[TBL] [Abstract][Full Text] [Related]
8. Biophysical interaction of temozolomide and its active metabolite with biomembrane models: The relevance of drug-membrane interaction for Glioblastoma Multiforme therapy.
Ramalho MJ; Andrade S; Coelho MÁN; Loureiro JA; Pereira MC
Eur J Pharm Biopharm; 2019 Mar; 136():156-163. PubMed ID: 30682492
[TBL] [Abstract][Full Text] [Related]
9. The interaction of a β2 adrenoceptor agonist drug with biomimetic cell membrane models: The case of terbutaline sulphate.
Loureiro JA; Andrade S; Ramalho MJ; Oliveira N; Pereira MC
Life Sci; 2021 Nov; 285():119992. PubMed ID: 34592235
[TBL] [Abstract][Full Text] [Related]
10. A correlation between lipid domain shape and binary phospholipid mixture composition in free standing bilayers: A two-photon fluorescence microscopy study.
Bagatolli LA; Gratton E
Biophys J; 2000 Jul; 79(1):434-47. PubMed ID: 10866969
[TBL] [Abstract][Full Text] [Related]
11. Aspirin inhibits formation of cholesterol rafts in fluid lipid membranes.
Alsop RJ; Toppozini L; Marquardt D; Kučerka N; Harroun TA; Rheinstädter MC
Biochim Biophys Acta; 2015 Mar; 1848(3):805-12. PubMed ID: 25475646
[TBL] [Abstract][Full Text] [Related]
12. A combined fluorescence spectroscopy, confocal and 2-photon microscopy approach to re-evaluate the properties of sphingolipid domains.
Pinto SN; Fernandes F; Fedorov A; Futerman AH; Silva LC; Prieto M
Biochim Biophys Acta; 2013 Sep; 1828(9):2099-110. PubMed ID: 23702462
[TBL] [Abstract][Full Text] [Related]
13. Sustained Epigenetic Drug Delivery Depletes Cholesterol-Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids.
Raghavan V; Vijayaraghavalu S; Peetla C; Yamada M; Morisada M; Labhasetwar V
Langmuir; 2015 Oct; 31(42):11564-73. PubMed ID: 26439800
[TBL] [Abstract][Full Text] [Related]
14. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
[TBL] [Abstract][Full Text] [Related]
15. New Insights on the Biophysical Interaction of Resveratrol with Biomembrane Models: Relevance for Its Biological Effects.
Neves AR; Nunes C; Reis S
J Phys Chem B; 2015 Sep; 119(35):11664-72. PubMed ID: 26237152
[TBL] [Abstract][Full Text] [Related]
16. Differential interactions of rifabutin with human and bacterial membranes: implication for its therapeutic and toxic effects.
Pinheiro M; Arêde M; Nunes C; Caio JM; Moiteiro C; Lúcio M; Reis S
J Med Chem; 2013 Jan; 56(2):417-26. PubMed ID: 23215016
[TBL] [Abstract][Full Text] [Related]
17. Interaction of natural compounds with biomembrane models: A biophysical approach for the Alzheimer's disease therapy.
Andrade S; Ramalho MJ; Loureiro JA; Pereira MC
Colloids Surf B Biointerfaces; 2019 Aug; 180():83-92. PubMed ID: 31030024
[TBL] [Abstract][Full Text] [Related]
18. The influence of charge and lipophilicity of daunorubicin and idarubicin on their penetration of model biological membranes - Langmuir monolayer and electrochemical studies.
Matyszewska D
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183104. PubMed ID: 31672546
[TBL] [Abstract][Full Text] [Related]
19. The influence of cationic lipoid - 1-palmitoyl-2-oleoyl-sn-glycero-3-ethylphosphocholine - on model lipid membranes.
Mach M; Kowalska M; Olechowska K; Hąc-Wydro K; Wydro P
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183088. PubMed ID: 31676373
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
Caillon L; Lequin O; Khemtémourian L
Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
